Recursion Pharmaceuticals (RXRX) Announces $150M Private Placement at $9.80/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. HUM
2. SPCX
3. ALHC
4. TMUS
5. PEP
6. AXP
7. T
8. SPY
9. CVS
10. UNH

Go back to Recursion Pharmaceuticals (RXRX) Announces $150M Private Placement at $9.80/sh

Recursion Announces $150 Million Private Placement to New and Existing Investors, led by Kinnevik AB

October 25, 2022 8:00 AM EDT

SALT LAKE CITY, Oct. 25, 2022 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, announced today that it has entered into a stock purchase agreement for the sale of an aggregate of approximately 15.3 million shares of its Class A common stock in a private placement, led by Kinnevik AB, with participation by Baillie Gifford, Mubadala Investment Company, Laurion Capital Management, Invus, and Platinum Asset Management. The... More